1. Home
  2. AMST vs ADVB Comparison

AMST vs ADVB Comparison

Compare AMST & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$2.32

Market Cap

11.8M

Sector

Technology

ML Signal

HOLD

ADVB

Advanced Biomed Inc. Common Stock

HOLD

Current Price

$0.36

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
ADVB
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
9.7M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
AMST
ADVB
Price
$2.32
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.0K
189.0K
Earning Date
10-24-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,505.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
68.56
N/A
52 Week Low
$2.00
$0.34
52 Week High
$6.27
$4.10

Technical Indicators

Market Signals
Indicator
AMST
ADVB
Relative Strength Index (RSI) 41.60 39.16
Support Level $2.25 $0.36
Resistance Level $2.48 $0.40
Average True Range (ATR) 0.16 0.04
MACD 0.04 -0.00
Stochastic Oscillator 81.40 4.48

Price Performance

Historical Comparison
AMST
ADVB

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: